P3‐023 : GENETIC VARIATION WITHIN GENES OF THE SPHINGOLIPID METABOLISM PATHWAY AND THEIR ASSOCIATION WITH ALZHEIMER'S DISEASE RISK AND RELATED PHENOTYPES

enthalten in: Alzheimer's & Dementia | 2014

von Laws, S. | Porter, T. | Creegan, R. | +16

P2‐409 : Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study

enthalten in: Alzheimer's & Dementia | 2012

von Laws, S. | Bender, S. | Rainey‐Smith, S. | +12

P2‐410 : Alzheimer's disease‐related changes in plasma brain‐derived neurotrophic factor levels: Data from the AIBL study

enthalten in: Alzheimer's & Dementia | 2012

von Rainey‐Smith, S. | Brown, B. | De Ruyck, K. | +12

P1‐010 : Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing

enthalten in: Alzheimer's & Dementia | 2012

von Gupta, V. | Wilson, A. | Rainey‐Smith, S. | +10

P3‐199 : Multi locus interactions in steroidogenic pathway genes predict Alzheimer's disease

enthalten in: Alzheimer's & Dementia | 2008

von Basson, J. | Wilson, A. | Haasl, R. | +1

P4‐220 : Identification of a negative feedback loop in the brain for the regulation of neurosteroid synthesis: Implications for Alzheimer's disease

enthalten in: Alzheimer's & Dementia | 2008

von Meethal, S. | Chan, H. | Ginsburg, E. | +4

P4–423 : Functional GnRH receptor signaling in neurons: Implications for the treatment of Alzheimer's disease

enthalten in: Alzheimer's & Dementia | 2006

von Atwood, C. | Salamat, M. | Roche, K. | +6